Stocks and Investing
Stocks and Investing
Mon, September 10, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, September 7, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, September 6, 2018
Madhu Kumar Upgraded (ARWR) to Strong Buy on, Sep 6th, 2018
Madhu Kumar of B. Riley Securities, Upgraded "Arrowhead Pharmaceuticals, Inc." (ARWR) to Strong Buy on, Sep 6th, 2018.
Madhu has made no other calls on ARWR in the last 4 months.
There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Madhu's Rating of Hold.
This is the rating of the analyst that currently disagrees with Madhu
- Elemer Piros of "Cantor Fitzgerald" Upgraded from Hold to Buy on, Wednesday, May 9th, 2018